SCHEMBL31108836

SCHEMBL31108836

CCOC(=O)C(C)(C)CCCCCC[C@H](OC)[C@@H](CCCCCCC(C)(C)C(=O)OCC)OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP4F2 P78329 3/20 0.63
▸ CYP4A11 Q02928 3/20 0.63
▸ HTT P42858 1/20 0.41
▸ ACACB O00763 1/20 0.41
▸ ACACA Q13085 1/20 0.41
▸ THRB P10828 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ CPB2 Q96IY4 2/20 0.36
▸ MMP8 P22894 1/20 0.34
▸ TBXAS1 P24557 1/20 0.34
▸ ZDHHC7 Q9NXF8 1/20 0.33
▸ ELANE P08246 1/20 0.33
▸ USP2 O75604 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ ACLY P53396 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31108917 1.00 CYP4F2 (0.63) CYP4F2CYP4A11HTTACACBACACA
SCHEMBL31108855 1.00 CYP4F2 (0.63) CYP4F2CYP4A11HTTACACBACACA
SCHEMBL31108879 1.00 CYP4F2 (0.63) CYP4F2CYP4A11HTTACACBACACA
SCHEMBL31108922 1.00 CYP4F2 (0.63) CYP4F2CYP4A11HTTACACBACACA
SCHEMBL31108844 1.00 CYP4F2 (0.63) CYP4F2CYP4A11HTTACACBACACA
SCHEMBL31108860 1.00 CYP4F2 (0.63) CYP4F2CYP4A11HTTACACBACACA
SCHEMBL31108918 1.00 CYP4F2 (0.63) CYP4F2CYP4A11HTTACACBACACA
SCHEMBL31108838 0.91 CYP4F2 (0.56) CYP4F2CYP4A11HTTACACBACACA
SCHEMBL31108843 0.91 CYP4F2 (0.56) CYP4F2CYP4A11HTTACACBACACA
SCHEMBL31108866 0.91 CYP4F2 (0.56) CYP4F2CYP4A11HTTACACBACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4695266-A1 SUBSTITUTED ALKANOIC-DIACIDS COMPOUND AND COMPOSITION AND USE THEREOF Meta Pharmaceuticals (HK) Limited (HK) 2026-02-18 — — EP disclosed
WO-2024213143-A1 SUBSTITUTED ALKANOIC-DIACIDS COMPOUND AND COMPOSITION AND USE THEREOF META PHARMACEUTICALS (HK) LIMITED (CN) 2024-10-17 — — WO disclosed
Send feedback